The COVID-19 vaccine eligibility for 2025 primarily targets those at highest risk of severe illness. Adults aged 75 years and over, residents in older adult care homes, and individuals aged 6 months and above with a weakened immune system or certain immunosuppressive conditions are eligible to receive the vaccine. This includes people undergoing treatments like chemotherapy, living with HIV, or requiring long-term immunosuppressive medication. People under 75 years are generally not routinely offered the vaccine unless they fall into the immunosuppressed or high-risk categories. Children and younger individuals with specific high-risk medical conditions may also be eligible. Summary of eligibility criteria for the 2025 COVID-19 vaccine:
- Adults 75 years and older
- Residents in older adult care homes
- Individuals aged 6 months and above with weakened immune systems or specific immunosuppressive conditions, including organ transplant recipients, chemotherapy patients, and those with certain genetic immune disorders.
These changes reflect a narrowing of eligibility compared to previous years to focus on those most vulnerable to severe COVID-19 complications.
